Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow, Masahiro Mori, Satoshi Kuwabara, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Neuromyelitis optica
Sven Jarius, Friedemann Paul, Brian G. Weinshenker, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 335
Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)
Gustavo C. Román, Fernando Gracia, Antonio Torres, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 220
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Hadas Stiebel‐Kalish, Mark A. Hellmann, Michael Mimouni, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 4
Open Access | Times Cited: 175
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Sven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 132
Neuromyelitis optica spectrum disorder
Janine B. Beekman, Aysha Keisler, Omar Pedraza, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 4
Open Access | Times Cited: 105
Treatment of MOG antibody associated disorders: results of an international survey
Daniel Whittam, Venkatraman Karthikeayan, Emily Gibbons, et al.
Journal of Neurology (2020) Vol. 267, Iss. 12, pp. 3565-3577
Open Access | Times Cited: 101
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L. Bruijstens, Eva‐Maria Wendel, Christian Lechner, et al.
European Journal of Paediatric Neurology (2020) Vol. 29, pp. 41-53
Open Access | Times Cited: 95
AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis
Angeliki Filippatou, Loulwah Mukharesh, Shiv Saidha, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 82
Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD
Dean M. Wingerchuk, Kazuo Fujihara, Jacqueline Palace, et al.
Annals of Neurology (2021) Vol. 89, Iss. 6, pp. 1088-1098
Open Access | Times Cited: 72
Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
Tetsuya Akaishi, Toshiyuki Takahashi, Tatsuro Misu, et al.
Neurology (2021) Vol. 97, Iss. 1
Open Access | Times Cited: 72
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
Stanislas Demuth, Maxime Guillaume, Bertrand Bourre, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 45
NMOSD and MOGAD: an evolving disease spectrum
Akiyuki Uzawa, Frederike Cosima Oertel, Masahiro Mori, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 11
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodology
Ricardo Alonso, Víctor M. Rivera, Edgar German Carnero Contentti, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106244-106244
Closed Access | Times Cited: 1
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder
H. Chen, Wei Qiu, Q. Zhang, et al.
European Journal of Neurology (2016) Vol. 24, Iss. 1, pp. 219-226
Closed Access | Times Cited: 72
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
Agnieshka Agasing, Qi Wu, Bhuwan Khatri, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69
Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
Frederike Cosima Oertel, Olivier Outteryck, Benjamin Knier, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 62
Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies
Susanna Asseyer, Graham Cooper, Friedemann Paul
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 61
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features
Frederike Cosima Oertel, Jana Schließeit, Alexander U. Brandt, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 60
Retinal correlates of neurological disorders
Timothy E. Yap, Shiama Balendra, Melanie Almonte, et al.
Therapeutic Advances in Chronic Disease (2019) Vol. 10
Open Access | Times Cited: 55
Prodromal headache in MOG-antibody positive optic neuritis
Susanna Asseyer, Josh Hamblin, Silvia Messina, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 40, pp. 101965-101965
Closed Access | Times Cited: 54
Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
Tetsuya Akaishi, Toshiyuki Takahashi, Tatsuro Misu, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 53
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
Takashi Yamamura, Brian G. Weinshenker, Michael R. Yeaman, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 66, pp. 104025-104025
Open Access | Times Cited: 36
Effectiveness and tolerability of immunosuppressants and monoclonal antibodies in preventive treatment of neuromyelitis optica spectrum disorders: A systematic review and network meta-analysis
Wenjuan Huang, Liang Wang, Baojingzi Zhang, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 35, pp. 246-252
Closed Access | Times Cited: 52
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 – continuity and change
Hans‐Peter Hartung, Jonas Graf, Orhan Aktaş, et al.
Current Opinion in Neurology (2019) Vol. 32, Iss. 3, pp. 327-337
Closed Access | Times Cited: 50
Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis
Frederike Cosima Oertel, Hanna Zimmermann, Alexander U. Brandt, et al.
Expert Review of Neurotherapeutics (2018) Vol. 19, Iss. 1, pp. 31-43
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top